Brief Report: Aumolertinib as a Switch Therapy in Osimertinib-Intolerant NSCLC: The ACTIVE Trial.

Tagrisso (osimertinib) - AstraZeneca

Ameile (aumolertinib) - Jiangsu Hansoh Pharma

http://www.ncbi.nlm.nih.gov/pubmed/42341878

Biao Yao; Chun Huang; Conghua Xie; Hongyan Huang; Jueping Feng; Renhua Guo; Shun Lu; Wenxiu Yao; Yongsheng Li; Yueyin Pan; Ziming Li

Jun 25, 2026